Stock Taper
| DATE | TYPE | RATIO |
|---|---|---|
| 2024-05-28 | Reverse | 1:15 |
| 2023-11-21 | Reverse | 1:25 |
Tharimmune, Inc., founded in 2017 in Bridgewater, NJ, is a clinical-stage biotech developing therapies for inflammation, immunology, and pruritus, including TH104 for treating the rare liver disease PBC.

Canton Strategic Holdings focuses on its digital asset treasury, leveraging Canton Coin and the Canton Network to promote institutional blockchain adoption, network security, and financial market digitization.
Overall rating: C
| PEER | PRICE | |
|---|---|---|
ANL | $15.74 | COMPARE |
APLM | $23.42 | COMPARE |
AIMD | $1.48 | COMPARE |
BLRX | $2.49 | COMPARE |
LNAI | $2.33 | COMPARE |
ICU | $3.54 | COMPARE |
ADTX | $0.00 | COMPARE |
MBRX | $0.77 | COMPARE |